Dergiler / Experimental Biomedical Research / 2020 / Cilt: 3 - Sayı: 3

The efficacy of multiparametric prostate magnetic resonance imaging in the diagnosis and treatment of prostate cancer

Sayfa
167–175
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The results of our study show that mpMRI can gain a new and important place in urology due to the guidance it provides in biopsies, facilitating targeted biopsy, its effectiveness in determining treatment modalities and its importance in post-PCa treatment follow-ups.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: To investigate the accuracy of multiparametric prostate magnetic resonance imaging (mpMRI) in determining the diagnosis and treatment options of prostate cancer (PCa), and its pathology correlation.
📊
Temel Bulgular & Veri:Methods: Between October 2017 and January 2018, 73 patients were subjected to an mpMRI at our clinic.
💡
Sonuç & Katkı:Conclusion: The results of our study show that mpMRI can gain a new and important place in urology due to the guidance it provides in biopsies, facilitating targeted biopsy, its effectiveness in determining treatment modalities and its importance in post-PCa treatment follow-ups.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: To investigate the accuracy of multiparametric prostate magnetic resonance imaging (mpMRI) in determining the diagnosis and treatment options of prostate cancer (PCa), and its pathology correlation. Methods: Between October 2017 and January 2018, 73 patients were subjected to an mpMRI at our clinic. Of these patients, 11 were radical prostatectomy (RP) after treatment, and four were postradiation therapy (RT) follow-up. The remaining 58 patients were assigned to the PSA elevation and / or positive digital rectal examination (DRE) patient group in this study and their outcomes were evaluated. Results: Of the 58 patients included in the study, 13 were found to have a PI-RADS 5 on mpMRI and in 9 (90%) of 10 patients undergoing simultaneous biopsy, PCa was detected. The biopsy results of all cases evaluated as PI-RADS 1 were benign. All of the patients who were ISUP 3 and above had a PI-RADS 5. Patients with a PI-RADS score of 4 and above being ISUP 2 and above was statistically significant (p=0.011). A case had undergone a previous radical prostatectomy assessment revealed that tPSA increased to 2 ng/ml during the follow-up, and so RT was added to the treatment; although LAP was identified in the left iliac region on an mpMRI performed upon the continued increase of tPSA. During the follow-ups of the patient who had regional RT, the tPSA dropped below 0.01 ng/ml. Conclusion: The results of our study show that mpMRI can gain a new and important place in urology due to the guidance it provides in biopsies, facilitating targeted biopsy, its effectiveness in determining treatment modalities and its importance in post-PCa treatment follow-ups.

🔖

Bu Makaleye Atıf Yap

ÖZCAN, S., AKIN, Y., KÖSE, O., COŞKUN, M., ULUÇ, M. E., GÖRGEL, S., YILMAZ, Y., YAĞLI, Ö. F. (2020). The efficacy of multiparametric prostate magnetic resonance imaging in the diagnosis and treatment of prostate cancer. Experimental Biomedical Research, Cilt: 3 - Sayı: 3, 167–175. https://ajindex.com/articles/156994

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Tao Z, Shi A, Wang K, et al. Epidemiology of prostate cancer: current status. Eur Rev Med Pharmacol Sci. 2015;19(5):805-12
  2. Merseburger A, Falkenberg AB, Kornilova OJ. New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular risk. World J Urol. 2019;37(6):1085-93
  3. Panigrahi GK, Praharaj PP, Kittaka H, et al. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Med. 2019;8(3):1110-23
  4. AJCC. American Joint Committee on Cancer. [cited 2019 August 26]; Available from: https://cancerstaging.org/referencestools/quickreferences/Documents/ProstateL arge.pdf [5] NCCN. The National Comprehensive Cancer Network. [cited 2019 August 20]; Available from: https://www.nccn.org/professionals/physici an_gls/PDF/prostate.pdf [6] Moore CM, Kasivisvanathan V, Eggener S, et al. Standards of reporting for MRItargeted biopsy studies of the prostate: recommendations from an International Working Group. Eur Urol. 2013;64(4):544- 52. [7] de Rooij M, Hamoen EH, Fütterer JJ, et al. Accuracy of multiparametric MRI for prostate cancer detection: a metaanalysis.AJR Am J Roentgenol. 2014;202(2):343-51
  5. Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016; 69(1):16-40
  6. Turkbey B, Brown AM, Sankineni S, et al. Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin. 2016; 66(4):326-36. [10]EAU. Prostate Cancer Guideline: European Association of Urology. [cited 2019 August 15]; Available from: https://uroweb.org/guideline/prostatecancer [11]Heck MM, Souvatzoglou M, Retz M, et al. Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2014;41(4):694- 701. [12]Pasoglou V, Larbi A, Collette L, et al. One‐ step TNM staging of high‐risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all‐in‐ one” imaging approach? The Prostate. 2014;74(5):469-77. [13]Lecouvet FE, El Mouedden J, Collette L, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-st